
Callisto Inc. is a Tokyo-based startup founded in June 2022, focused on revolutionizing medical AI and drug discovery AI. They operate a platform that aggregates and sells diverse, high-quality medical image datasets (radiology, pathology, clinical information, molecular diagnostic results) for AI research and development, in collaboration with medical institutions. Their business model involves anonymizing and standardizing medical data provided by healthcare facilities, then selling these datasets to medical AI companies, medical device manufacturers, and pharmaceutical companies. They also offer custom AI development and consulting services in the medical and drug discovery fields. Callisto aims to contribute to global healthcare by providing data sets for clinical research and training, while also giving back a portion of the revenue to data-providing institutions, creating a sustainable ecosystem.

Callisto Inc. is a Tokyo-based startup founded in June 2022, focused on revolutionizing medical AI and drug discovery AI. They operate a platform that aggregates and sells diverse, high-quality medical image datasets (radiology, pathology, clinical information, molecular diagnostic results) for AI research and development, in collaboration with medical institutions. Their business model involves anonymizing and standardizing medical data provided by healthcare facilities, then selling these datasets to medical AI companies, medical device manufacturers, and pharmaceutical companies. They also offer custom AI development and consulting services in the medical and drug discovery fields. Callisto aims to contribute to global healthcare by providing data sets for clinical research and training, while also giving back a portion of the revenue to data-providing institutions, creating a sustainable ecosystem.